Inflammasomes and Pyroptosis of Liver Cells in Liver Fibrosis
Tóm tắt
Inflammasomes are multiprotein complexes that can sense danger signals and activate caspase-1 to mediate pro-inflammatory cytokines release and pyroptotic cell death. There are two main canonical and non-canonical signaling pathways that trigger inflammasome activation. Inflammasomes are expressed and assembled in parenchymal and nonparenchymal cells in response to liver injury in the liver. Additionally, the hepatocytes, biliary epithelial cells (cholangiocytes), hepatic stellate cells (HSCs), hepatic macrophages, and liver sinusoidal endothelial cells (LSECs) contribute to liver fibrosis
Từ khóa
Tài liệu tham khảo
Broz, 2016, Inflammasomes: Mechanism of Assembly, Regulation and Signalling, Nat Rev Immunol, 16, 10.1038/nri.2016.58
Christgen, 2020, Toward Targeting Inflammasomes: Insights Into Their Regulation and Activation, Cell Res, 30, 10.1038/s41422-020-0295-8
Zeng, 2021, Circular Rna as an Epigenetic Regulator in Chronic Liver Diseases, Cells, 10, 10.3390/cells10081945
Cai, 2021, Mechanism and Therapeutic Opportunities of Histone Modifications in Chronic Liver Disease, Front Pharmacol, 12, 10.3389/fphar.2021.784591
Kisseleva, 2021, Molecular and Cellular Mechanisms of Liver Fibrosis and Its Regression, Nat Rev Gastroenterol Hepatol, 18, 10.1038/s41575-020-00372-7
Tsuchida, 2017, Mechanisms of Hepatic Stellate Cell Activation, Nat Rev Gastroenterol Hepatol, 14, 397, 10.1038/nrgastro.2017.38
Cao, 2021, Regulation and Functional Roles of Chemokines in Liver Diseases, Nat Rev Gastroenterol Hepatol, 18, 10.1038/s41575-021-00444-2
Vanaja, 2015, Mechanisms of Inflammasome Activation: Recent Advances and Novel Insights, Trends Cell Biol, 25, 10.1016/j.tcb.2014.12.009
Martínez-Cardona, 2018, Aim2 Deficiency Reduces the Development of Hepatocellular Carcinoma in Mice, Int J Cancer, 143, 2997, 10.1002/ijc.31827
Faustin, 2007, Reconstituted Nalp1 Inflammasome Reveals Two-Step Mechanism of Caspase-1 Activation, Mol Cell, 25, 10.1016/j.molcel.2007.01.032
Finger, 2012, Autolytic Proteolysis Within the Function to Find Domain (Fiind) Is Required for Nlrp1 Inflammasome Activity, J Biol Chem, 287, 10.1074/jbc.M112.378323
Pelegrin, 2006, Pannexin-1 Mediates Large Pore Formation and Interleukin-1beta Release by the Atp-Gated P2x7 Receptor, EMBO J, 25, 10.1038/sj.emboj.7601378
Wickliffe, 2008, Anthrax Lethal Toxin-Induced Inflammasome Formation and Caspase-1 Activation Are Late Events Dependent on Ion Fluxes and the Proteasome, Cell Microbiol, 10, 10.1111/j.1462-5822.2007.01044.x
Latz, 2013, Activation and Regulation of the Inflammasomes, Nat Rev Immunol, 13, 397, 10.1038/nri3452
Duncan, 2009, Neisseria Gonorrhoeae Activates the Proteinase Cathepsin B to Mediate the Signaling Activities of the Nlrp3 and Asc-Containing Inflammasome, J Immunol, 182, 10.4049/jimmunol.0802696
Mariathasan, 2006, Cryopyrin Activates the Inflammasome in Response to Toxins and Atp, Nature, 440, 10.1038/nature04515
Martinon, 2006, Gout-Associated Uric Acid Crystals Activate the Nalp3 Inflammasome, Nature, 440, 10.1038/nature04516
Halle, 2008, The Nalp3 Inflammasome Is Involved in the Innate Immune Response to Amyloid-Beta, Nat Immunol, 9, 10.1038/ni.1636
Woolbright, 2017, Role of the Inflammasome in Acetaminophen-Induced Liver Injury and Acute Liver Failure, J Hepatol, 66, 10.1016/j.jhep.2016.11.017
Miao, 2006, Cytoplasmic Flagellin Activates Caspase-1 and Secretion of Interleukin 1beta Via Ipaf, Nat Immunol, 7, 10.1038/ni1344
Mariathasan, 2004, Differential Activation of the Inflammasome by Caspase-1 Adaptors Asc and Ipaf, Nature, 430, 10.1038/nature02664
Miao, 2010, Innate Immune Detection of the Type Iii Secretion Apparatus Through the Nlrc4 Inflammasome, Proc Natl Acad Sci U S A, 107, 10.1073/pnas.0913087107
Tenthorey, 2014, Molecular Basis for Specific Recognition of Bacterial Ligands by Naip/Nlrc4 Inflammasomes, Mol Cell, 54, 17, 10.1016/j.molcel.2014.02.018
Etienne-Mesmin, 2016, Hepatocyte Toll-Like Receptor 5 Promotes Bacterial Clearance and Protects Mice Against High-Fat Diet-Induced Liver Disease, Cell Mol Gastroenterol Hepatol, 2, 584, 10.1016/j.jcmgh.2016.04.007
Chen, 2019, Nlrc4 Inflammasome Activation Regulated by Tnf-α Promotes Inflammatory Responses in Nonalcoholic Fatty Liver Disease, Biochem Biophys Res Commun, 511, 10.1016/j.bbrc.2019.02.099
Rathinam, 2010, The Aim2 Inflammasome Is Essential for Host Defense Against Cytosolic Bacteria and DNA Viruses, Nat Immunol, 11, 395, 10.1038/ni.1864
Hornung, 2009, Aim2 Recognizes Cytosolic Dsdna and Forms a Caspase-1-Activating Inflammasome With Asc, Nature, 458, 10.1038/nature07725
Mambwe, 2019, Tyrosine Dephosphorylation of Asc Modulates the Activation of the Nlrp3 and Aim2 Inflammasomes, Front Immunol, 10, 10.3389/fimmu.2019.01556
Xu, 2021, Mitochondrial DNA Enables Aim2 Inflammasome Activation and Hepatocyte Pyroptosis in Nonalcoholic Fatty Liver Disease, Am J Physiol Gastrointest Liver Physiol, 320, 10.1152/ajpgi.00431.2020
Sun, 2017, Redox-Dependent Regulation of Hepatocyte Absent in Melanoma 2 Inflammasome Activation in Sterile Liver Injury in Mice, Hepatology, 65, 10.1002/hep.28893
Lozano-Ruiz, 2015, Absent in Melanoma 2 Triggers a Heightened Inflammasome Response in Ascitic Fluid Macrophages of Patients With Cirrhosis, J Hepatol, 62, 64, 10.1016/j.jhep.2014.08.027
Wang, 2021, Perfluoroalkyl Substance Pollutants Activate the Innate Immune System Through the Aim2 Inflammasome, Nat Commun, 12, 2915, 10.1038/s41467-021-23201-0
Schnappauf, 2019, The Pyrin Inflammasome in Health and Disease, Front Immunol, 10, 10.3389/fimmu.2019.01745
Heilig, 2018, Function and Mechanism of the Pyrin Inflammasome, Eur J Immunol, 48, 10.1002/eji.201746947
Mulvihill, 2018, Mechanism of Membrane Pore Formation by Human Gasdermin-D, EMBO J, 37, 10.15252/embj.201798321
Rathinam, 2016, Inflammasome Complexes: Emerging Mechanisms and Effector Functions, Cell, 165, 792, 10.1016/j.cell.2016.03.046
He, 2015, Gasdermin D Is an Executor of Pyroptosis and Required for Interleukin-1β Secretion, Cell Res, 25, 10.1038/cr.2015.139
Shi, 2015, Cleavage of Gsdmd by Inflammatory Caspases Determines Pyroptotic Cell Death, Nature, 526, 10.1038/nature15514
Kist, 2021, Cell Death Pathways: Intricate Connections and Disease Implications, EMBO J, 40, 10.15252/embj.2020106700
Kayagaki, 2015, Caspase-11 Cleaves Gasdermin D for Non-Canonical Inflammasome Signalling, Nature, 526, 10.1038/nature15541
Bauernfeind, 2009, Cutting Edge: Nf-Kappab Activating Pattern Recognition and Cytokine Receptors License Nlrp3 Inflammasome Activation by Regulating Nlrp3 Expression, J Immunol, 183, 10.4049/jimmunol.0901363
Zhou, 2011, A Role for Mitochondria in Nlrp3 Inflammasome Activation, Nature, 469, 10.1038/nature09663
Rühl, 2015, Caspase-11 Activates a Canonical Nlrp3 Inflammasome by Promoting K(+) Efflux, Eur J Immunol, 45, 10.1002/eji.201545772
Parola, 2019, Liver Fibrosis: Pathophysiology, Pathogenetic Targets and Clinical Issues, Mol Aspects Med, 65, 37, 10.1016/j.mam.2018.09.002
Marrone, 2016, Sinusoidal Communication in Liver Fibrosis and Regeneration, J Hepatol, 65, 10.1016/j.jhep.2016.04.018
Gao, 2021, Endothelial P300 Promotes Portal Hypertension and Hepatic Fibrosis Through C-C Motif Chemokine Ligand 2-Mediated Angiocrine Signaling, Hepatology, 73, 10.1002/hep.31617
Gao, 2020, Hepatic Stellate Cell Autophagy Inhibits Extracellular Vesicle Release to Attenuate Liver Fibrosis, J Hepatol, 73, 10.1016/j.jhep.2020.04.044
Szabo, 2015, Inflammasome Activation and Function in Liver Disease, Nat Rev Gastroenterol Hepatol, 12, 387, 10.1038/nrgastro.2015.94
Schuster-Gaul, 2020, Ask1 Inhibition Reduces Cell Death and Hepatic Fibrosis in an Nlrp3 Mutant Liver Injury Model, JCI Insight, 5, 10.1172/jci.insight.123294
Luan, 2018, Inflammasome: A Double-Edged Sword in Liver Diseases, Front Immunol, 9, 10.3389/fimmu.2018.02201
Wree, 2014, Nlrp3 Inflammasome Activation Results in Hepatocyte Pyroptosis, Liver Inflammation, and Fibrosis in Mice, Hepatology, 59, 898, 10.1002/hep.26592
Zhang, 2015, Reactive Oxygen Species-Induced Txnip Drives Fructose-Mediated Hepatic Inflammation and Lipid Accumulation Through Nlrp3 Inflammasome Activation, Antioxid Redox Signal, 22, 10.1089/ars.2014.5868
Wan, 2016, Uric Acid Regulates Hepatic Steatosis and Insulin Resistance Through the Nlrp3 Inflammasome-Dependent Mechanism, J Hepatol, 64, 10.1016/j.jhep.2015.11.022
Zhang, 2019, Impaired Mitophagy Triggers Nlrp3 Inflammasome Activation During the Progression From Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis, Lab Invest, 99, 10.1038/s41374-018-0177-6
Yu, 2019, Liraglutide Ameliorates Non-Alcoholic Steatohepatitis by Inhibiting Nlrp3 Inflammasome and Pyroptosis Activation Via Mitophagy, Eur J Pharmacol, 864, 10.1016/j.ejphar.2019.172715
Zhu, 2021, Caspase-11-Mediated Hepatocytic Pyroptosis Promotes the Progression of Nonalcoholic Steatohepatitis, Cell Mol Gastroenterol Hepatol, 12, 10.1016/j.jcmgh.2021.04.009
Gaul, 2021, Hepatocyte Pyroptosis and Release of Inflammasome Particles Induce Stellate Cell Activation and Liver Fibrosis, J Hepatol, 74, 10.1016/j.jhep.2020.07.041
Heo, 2019, Alcohol Dysregulates Mir-148a in Hepatocytes Through Foxo1, Facilitating Pyroptosis Via Txnip Overexpression, Gut, 68, 10.1136/gutjnl-2017-315123
Khanova, 2018, Pyroptosis by Caspase11/4-Gasdermin-D Pathway in Alcoholic Hepatitis in Mice and Patients, Hepatology, 67, 10.1002/hep.29645
Frissen, 2021, Bidirectional Role of Nlrp3 During Acute and Chronic Cholestatic Liver Injury, Hepatology, 73, 10.1002/hep.31494
Lebeaupin, 2018, Bax Inhibitor-1 Protects From Nonalcoholic Steatohepatitis by Limiting Inositol-Requiring Enzyme 1 Alpha Signaling in Mice, Hepatology, 68, 10.1002/hep.29847
Lebeaupin, 2015, Er Stress Induces Nlrp3 Inflammasome Activation and Hepatocyte Death, Cell Death Dis, 6, e1879, 10.1038/cddis.2015.248
Han, 2018, Fxr Inhibits Endoplasmic Reticulum Stress-Induced Nlrp3 Inflammasome in Hepatocytes and Ameliorates Liver Injury, Cell Rep, 24, 10.1016/j.celrep.2018.07.068
Koh, 2021, Sphingomyelin Synthase 1 Mediates Hepatocyte Pyroptosis to Trigger Non-Alcoholic Steatohepatitis, Gut, 70, 10.1136/gutjnl-2020-322509
Kazankov, 2019, The Role of Macrophages in Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis, Nat Rev Gastroenterol Hepatol, 16, 10.1038/s41575-018-0082-x
Tacke, 2017, Targeting Hepatic Macrophages to Treat Liver Diseases, J Hepatol, 66, 10.1016/j.jhep.2017.02.026
Wang, 2017, The Tir/Bb-Loop Mimetic as-1 Prevents Non-Alcoholic Steatohepatitis and Hepatic Insulin Resistance by Inhibiting Nlrp3-Asc Inflammasome Activation, Br J Pharmacol, 174, 10.1111/bph.13786
Wang, 2021, Ginseng Saponin Enriched in Rh1 and Rg2 Ameliorates Nonalcoholic Fatty Liver Disease by Inhibiting Inflammasome Activation, Nutrients, 13, 10.3390/nu13030856
Mohammed, 2021, Role of Necroptosis in Chronic Hepatic Inflammation and Fibrosis in a Mouse Model of Increased Oxidative Stress, Free Radic Biol Med, 164, 10.1016/j.freeradbiomed.2020.12.449
Wang, 2021, Myeloid Nrf2 Deficiency Aggravates Non-Alcoholic Steatohepatitis Progression by Regulating Yap-Mediated Nlrp3 Inflammasome Signaling, iScience, 24, 10.1016/j.isci.2021.102427
Tao, 2021, Rip1 Kinase Activity Promotes Steatohepatitis Through Mediating Cell Death and Inflammation in Macrophages, Cell Death Differ, 28, 10.1038/s41418-020-00668-w
Shi, 2020, Tgr5 Regulates Macrophage Inflammation in Nonalcoholic Steatohepatitis by Modulating Nlrp3 Inflammasome Activation, Front Immunol, 11, 10.3389/fimmu.2020.609060
Miura, 2013, Toll-Like Receptor 2 and Palmitic Acid Cooperatively Contribute to the Development of Nonalcoholic Steatohepatitis Through Inflammasome Activation in Mice, Hepatology, 57, 10.1002/hep.26081
Shen, 2017, Dietary Pufas Attenuate Nlrp3 Inflammasome Activation Via Enhancing Macrophage Autophagy, J Lipid Res, 58, 10.1194/jlr.M075879
Liu, 2019, Tim-4 Inhibits Nlrp3 Inflammasome Via the Lkb1/Ampkα Pathway in Macrophages, J Immunol, 203, 990, 10.4049/jimmunol.1900117
Kim, 2017, Ezetimibe Ameliorates Steatohepatitis Via Amp Activated Protein Kinase-Tfeb-Mediated Activation of Autophagy and Nlrp3 Inflammasome Inhibition, Autophagy, 13, 10.1080/15548627.2017.1356977
Ioannou, 2015, Cholesterol-Lowering Drugs Cause Dissolution of Cholesterol Crystals and Disperse Kupffer Cell Crown-Like Structures During Resolution of Nash, J Lipid Res, 56, 10.1194/jlr.M053785
Antonopoulos, 2015, Caspase-8 as an Effector and Regulator of Nlrp3 Inflammasome Signaling, J Biol Chem, 290, 10.1074/jbc.M115.652321
Zhang, 2014, Flavonoid Apigenin Inhibits Lipopolysaccharide-Induced Inflammatory Response Through Multiple Mechanisms in Macrophages, PloS One, 9, 10.1371/journal.pone.0107072
Hua, 2015, Cyclooxygenase-2 Regulates Nlrp3 Inflammasome-Derived Il-1β Production, J Cell Physiol, 230, 10.1002/jcp.24815
Gao, 2016, Celecoxib and Octreotide Synergistically Ameliorate Portal Hypertension Via Inhibition of Angiogenesis in Cirrhotic Rats, Angiogenesis, 19, 10.1007/s10456-016-9522-9
Tai, 2021, Celecoxib Reduces Hepatic Vascular Resistance in Portal Hypertension by Amelioration of Endothelial Oxidative Stress, J Cell Mol Med, 25, 10.1111/jcmm.16968
Tang, 2021, Celecoxib Ameliorates Liver Cirrhosis Via Reducing Inflammation and Oxidative Stress Along Spleen-Liver Axis in Rats, Life Sci, 272, 10.1016/j.lfs.2021.119203
Su, 2020, Celecoxib Attenuates Hepatocyte Apoptosis by Inhibiting Endoplasmic Reticulum Stress in Thioacetamide-Induced Cirrhotic Rats, World J Gastroenterol, 26, 10.3748/wjg.v26.i28.4094
Shang, 2018, Leucodin Attenuates Inflammatory Response in Macrophages and Lipid Accumulation in Steatotic Hepatocytes Via P2x7 Receptor Pathway: A Potential Role in Alcoholic Liver Disease, BioMed Pharmacother, 107, 10.1016/j.biopha.2018.08.009
Petrasek, 2015, Metabolic Danger Signals, Uric Acid and Atp, Mediate Inflammatory Cross-Talk Between Hepatocytes and Immune Cells in Alcoholic Liver Disease, J Leukoc Biol, 98, 10.1189/jlb.3AB1214-590R
Mathews, 2013, Therapeutic Potential of Interleukin 1 Inhibitors in the Treatment of Alcoholic Liver Disease, Hepatology, 57, 10.1002/hep.26336
Kim, 2018, Spliceosome-Associated Protein 130 Exacerbates Alcohol-Induced Liver Injury by Inducing Nlrp3 Inflammasome-Mediated Il-1β in Mice, Am J Pathol, 188, 10.1016/j.ajpath.2017.12.010
Orecchioni, 2019, Macrophage Polarization: Different Gene Signatures in M1(Lps+) Vs. Classically and M2(Lps-) Vs. Alternatively Activated Macrophages, Front Immunol, 10, 10.3389/fimmu.2019.01084
Ilyas, 2019, Decreased Macrophage Autophagy Promotes Liver Injury and Inflammation From Alcohol, Alcohol Clin Exp Res, 43, 10.1111/acer.14041
Negash, 2013, Il-1β Production Through the Nlrp3 Inflammasome by Hepatic Macrophages Links Hepatitis C Virus Infection With Liver Inflammation and Disease, PloS Pathog, 9, 10.1371/journal.ppat.1003330
Serti, 2014, Monocytes Activate Natural Killer Cells Via Inflammasome-Induced Interleukin 18 in Response to Hepatitis C Virus Replication, Gastroenterology, 147, 209, 10.1053/j.gastro.2014.03.046
Negash, 2019, Modulation of Calcium Signaling Pathway by Hepatitis C Virus Core Protein Stimulates Nlrp3 Inflammasome Activation, PloS Pathog, 15, 10.1371/journal.ppat.1007593
Zhang, 2019, Nlrp3 Inflammasome Activation From Kupffer Cells Is Involved in Liver Fibrosis of Schistosoma Japonicum-Infected Mice Via Nf-κb, Parasit Vectors, 12, 29, 10.1186/s13071-018-3223-8
Wang, 2021, Psoralidin, a Major Component of Psoraleae Fructus, Induces Inflammasome Activation and Idiosyncratic Liver Injury, Int Immunopharmacol, 92, 10.1016/j.intimp.2020.107352
Jia, 2020, Nlrp3 Inflammasome and Related Cytokines Reflect the Immune Status of Patients With Hbv-Aclf, Mol Immunol, 120, 10.1016/j.molimm.2020.01.011
Zannetti, 2016, Characterization of the Inflammasome in Human Kupffer Cells in Response to Synthetic Agonists and Pathogens, J Immunol, 197, 10.4049/jimmunol.1502301
Sanches, 2020, Nlrp6 Plays an Important Role in Early Hepatic Immunopathology Caused by Schistosoma Mansoni Infection, Front Immunol, 11, 10.3389/fimmu.2020.00795
Silveira, 2017, Nlrp12 Negatively Regulates Proinflammatory Cytokine Production and Host Defense Against Brucella Abortus, Eur J Immunol, 47, 10.1002/eji.201646502
Maroni, 2017, Nlrp3 Activation Induces Il-18 Synthesis and Affects the Epithelial Barrier Function in Reactive Cholangiocytes, Am J Pathol, 187, 10.1016/j.ajpath.2016.10.010
Fabris, 2019, Pathobiology of Inherited Biliary Diseases: A Roadmap to Understand Acquired Liver Diseases, Nat Rev Gastroenterol Hepatol, 16, 497, 10.1038/s41575-019-0156-4
Tian, 2016, Galectin-3 Regulates Inflammasome Activation in Cholestatic Liver Injury, FASEB J, 30, 10.1096/fj.201600392RR
Watanabe, 2009, Inflammasome-Mediated Regulation of Hepatic Stellate Cells, Am J Physiol Gastrointest Liver Physiol, 296, 10.1152/ajpgi.90223.2008
Dong, 2020, Palmitic Acid Stimulates Nlrp3 Inflammasome Activation Through Tlr4-Nf-κb Signal Pathway in Hepatic Stellate Cells, Ann Transl Med, 8, 168, 10.21037/atm.2020.02.21
Duan, 2017, Palmitic Acid Elicits Hepatic Stellate Cell Activation Through Inflammasomes and Hedgehog Signaling, Life Sci, 176, 42, 10.1016/j.lfs.2017.03.012
Wu, 2015, Tetramethylpyrazine Reduces Inflammation in Liver Fibrosis and Inhibits Inflammatory Cytokine Expression in Hepatic Stellate Cells by Modulating Nlrp3 Inflammasome Pathway, IUBMB Life, 67, 10.1002/iub.1348
Zhao, 2019, P66shc Contributes to Liver Fibrosis Through the Regulation of Mitochondrial Reactive Oxygen Species, Theranostics, 9, 10.7150/thno.29620
Ning, 2017, Microrna-21 Mediates Angiotensin Ii-Induced Liver Fibrosis by Activating Nlrp3 Inflammasome/Il-1β Axis Via Targeting Smad7 and Spry1, Antioxid Redox Signal, 27, 1, 10.1089/ars.2016.6669
Cai, 2016, Angiotensin-(1-7) Improves Liver Fibrosis by Regulating the Nlrp3 Inflammasome Via Redox Balance Modulation, Antioxid Redox Signal, 24, 795, 10.1089/ars.2015.6498
Wang, 2020, Calcipotriol Inhibits Nlrp3 Signal Through Yap1 Activation to Alleviate Cholestatic Liver Injury and Fibrosis, Front Pharmacol, 11, 10.3389/fphar.2020.00200
Shan, 2020, Purine Signaling Regulating Hscs Inflammatory Cytokines Secretion, Activation, and Proliferation Plays a Critical Role in Alcoholic Liver Disease, Mol Cell Biochem, 466, 91, 10.1007/s11010-020-03691-0
Sasaki, 2017, Hepatitis C Virus-Induced Ccl5 Secretion From Macrophages Activates Hepatic Stellate Cells, Hepatology, 66, 10.1002/hep.29170
Arriola Benitez, 2019, Brucella Abortus Infection Elicited Hepatic Stellate Cell-Mediated Fibrosis Through Inflammasome-Dependent Il-1β Production, Front Immunol, 10, 10.3389/fimmu.2019.03036
Lu, 2017, Nlrp3 Inflammasome Activation Results in Liver Inflammation and Fibrosis in Mice Infected With Schistosoma Japonicum in a Syk-Dependent Manner, Sci Rep, 7, 8120, 10.1038/s41598-017-08689-1
Li, 2020, Role of Aldosterone in the Activation of Primary Mice Hepatic Stellate Cell and Liver Fibrosis Via Nlrp3 Inflammasome, J Gastroenterol Hepatol, 35, 10.1111/jgh.14961
Ridker, 2017, Antiinflammatory Therapy With Canakinumab for Atherosclerotic Disease, N Engl J Med, 377, 10.1056/NEJMoa1707914
Blasetti Fantauzzi, 2017, Deficiency of the Purinergic Receptor 2x(7) Attenuates Nonalcoholic Steatohepatitis Induced by High-Fat Diet: Possible Role of the Nlrp3 Inflammasome, Oxid Med Cell Longev, 2017, 10.1155/2017/8962458
Li, 2019, Activated Nk Cells Kill Hepatic Stellate Cells Via P38/Pi3k Signaling in a Trail-Involved Degranulation Manner, J Leukoc Biol, 105, 695, 10.1002/jlb.2a0118-031rr
Nilsson, 2020, Nkt Cells Promote Both Type 1 and Type 2 Inflammatory Responses in a Mouse Model of Liver Fibrosis, Sci Rep, 10, 21778, 10.1038/s41598-020-78688-2
Nichols, 2017, Naip/Nlrc4 Inflammasome Activation in Mrp8(+) Cells Is Sufficient to Cause Systemic Inflammatory Disease, Nat Commun, 8, 2209, 10.1038/s41467-017-02266-w
Szabo, 2017, Clinical Trial Design for Alcoholic Hepatitis, Semin Liver Dis, 37, 10.1055/s-0037-1608788
Larsen, 2007, Interleukin-1-Receptor Antagonist in Type 2 Diabetes Mellitus, N Engl J Med, 356, 10.1056/NEJMoa065213
Petrasek, 2012, Il-1 Receptor Antagonist Ameliorates Inflammasome-Dependent Alcoholic Steatohepatitis in Mice, J Clin Invest, 122, 10.1172/jci60777
Morrison, 2016, Intervention With a Caspase-1 Inhibitor Reduces Obesity-Associated Hyperinsulinemia, Non-Alcoholic Steatohepatitis and Hepatic Fibrosis in Ldlr-/-, Leiden Mice Int J Obes (Lond), 40, 10.1038/ijo.2016.74
Witek, 2009, Pan-Caspase Inhibitor Vx-166 Reduces Fibrosis in an Animal Model of Nonalcoholic Steatohepatitis, Hepatology, 50, 10.1002/hep.23167
Barreyro, 2015, The Pan-Caspase Inhibitor Emricasan (Idn-6556) Decreases Liver Injury and Fibrosis in a Murine Model of Non-Alcoholic Steatohepatitis, Liver Int, 35, 10.1111/liv.12570
Mridha, 2017, Nlrp3 Inflammasome Blockade Reduces Liver Inflammation and Fibrosis in Experimental Nash in Mice, J Hepatol, 66, 10.1016/j.jhep.2017.01.022
Baeza-Raja, 2020, Pharmacological Inhibition of P2rx7 Ameliorates Liver Injury by Reducing Inflammation and Fibrosis, PloS One, 15, 10.1371/journal.pone.0234038
Gabay, 2010, Il-1 Pathways in Inflammation and Human Diseases, Nat Rev Rheumatol, 6, 10.1038/nrrheum.2010.4
Yan, 2021, Mcc950 Ameliorates Acute Liver Injury Through Modulating Macrophage Polarization and Myeloid-Derived Suppressor Cells Function, Front Med (Lausanne), 8, 10.3389/fmed.2021.752223
von Moltke, 2012, Rapid Induction of Inflammatory Lipid Mediators by the Inflammasome in Vivo, Nature, 490, 10.1038/nature11351
Ramachandran, 2012, Differential Ly-6c Expression Identifies the Recruited Macrophage Phenotype, Which Orchestrates the Regression of Murine Liver Fibrosis, Proc Natl Acad Sci U S A, 109, 10.1073/pnas.1119964109
Weng, 2007, Ifn-Gamma Abrogates Profibrogenic Tgf-Beta Signaling in Liver by Targeting Expression of Inhibitory and Receptor Smads, J Hepatol, 46, 295, 10.1016/j.jhep.2006.09.014
Li, 2016, Intrahepatic Nk Cells Function Suppressed in Advanced Liver Fibrosis, Eur J Clin Invest, 46, 10.1111/eci.12669
Liang, 2018, Inhibition of Il-18 Reduces Renal Fibrosis After Ischemia-Reperfusion, BioMed Pharmacother, 106, 10.1016/j.biopha.2018.07.031
Prior, 2019, Liver Organoids: From Basic Research to Therapeutic Applications, Gut, 68, 10.1136/gutjnl-2019-319256